News Releases Year None2023202220212020201920182017 March 10, 2023 Ascendis Pharma to Participate in the Oppenheimer 33rd Annual Healthcare Conference February 16, 2023 Ascendis Pharma Reports Full Year 2022 Results February 7, 2023 Ascendis Pharma Announces Full Year 2022 Financial Results and Business Update Conference Call on February 16 January 8, 2023 Ascendis Pharma Provides Update on Vision 3x3 Strategic Roadmap at 41st Annual J.P. Morgan Healthcare Conference January 4, 2023 Online Enrollment Now Open for Physicians Requesting Expanded Access to Ascendis Pharma’s TransCon™ PTH for Eligible U.S. Adult Patients with Hypoparathyroidism January 3, 2023 Ascendis Pharma to Present at the 41st Annual J.P. Morgan Healthcare Conference
February 7, 2023 Ascendis Pharma Announces Full Year 2022 Financial Results and Business Update Conference Call on February 16
January 8, 2023 Ascendis Pharma Provides Update on Vision 3x3 Strategic Roadmap at 41st Annual J.P. Morgan Healthcare Conference
January 4, 2023 Online Enrollment Now Open for Physicians Requesting Expanded Access to Ascendis Pharma’s TransCon™ PTH for Eligible U.S. Adult Patients with Hypoparathyroidism
